Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Bioleaders Corp.

Headquarters: Daejeon, South Korea
Year Founded: 2000
Status: Public
Industry Sector: HealthTechnology
CEO: Sang-Jin Han
Number Of Employees: 59
Enterprise Value: $21,349,999
PE Ratio: -6.03
Exchange/Ticker 1: KOSDAQ:142760
Exchange/Ticker 2: N/A
Latest Market Cap: $31,667,735

BioCentury | Jun 5, 2021
Targets & Mechanisms

Going beyond genetic medicines for muscular dystrophy

Muscular dystrophy programs in the clinic cover not only a range of muscle mechanisms but also anti-fibrotic and anti-inflammation ones
BioCentury | Oct 10, 2016
Emerging Company Profile

Pellino play

How Bridge's first program attacks inflammatory disease on multiple fronts
BioCentury | Apr 15, 2013
Company News

AnGes, BioLeaders, GenoLac deal

BioCentury | Apr 16, 2012
Company News

AnGes, BioLeaders deal

Items per page:
1 - 5 of 5